Literature DB >> 1837314

Analysis of T cells bearing different isotypic forms of the gamma/delta T cell receptor in patients with systemic autoimmune diseases.

R Gerli1, E Agea, A Bertotto, R Tognellini, L Flenghi, F Spinozzi, A Velardi, F Grignani.   

Abstract

The expression of gamma/delta T cell receptor (TCR) on peripheral blood CD3+ cells circulating in 74 patients with different systemic autoimmune diseases was evaluated. There was a significant increase in the gamma/delta T cell number only in patients with primary Sjögren's syndrome (SS) and in untreated patients with systemic lupus erythematosus (SLE). Unlike healthy subjects, a subgroup of patients with SLE and SS displayed a marked increase in gamma/delta T cells. Immunosuppressive treatment of patients with active SLE led to a normalization of the gamma/delta T cell number. Analysis of surface phenotype showed that when patient gamma/delta T cells were expanded in the peripheral blood, they were not activated but bore "memory" markers. In addition, they preferentially expressed the disulfide linked form of the TCR, except in progressive systemic sclerosis where the nondisulfide form was displayed. Serial determinations in single patients demonstrated that the gamma/delta T cell increase is a persistent immunological feature in these patient subgroups.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1837314

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  13 in total

Review 1.  gamma delta T cells in autoimmunity.

Authors:  Z Yin; J Craft
Journal:  Springer Semin Immunopathol       Date:  2000

Review 2.  Tissue distribution, antigen specificity and effector functions of gamma delta T cells in human diseases.

Authors:  G De Libero
Journal:  Springer Semin Immunopathol       Date:  2000

3.  Gamma delta T cells in aqueous humour from untreated idiopathic uveitis patients.

Authors:  A Bertotto; F Spinozzi; C Vagliasindi; R Vaccaro
Journal:  Br J Ophthalmol       Date:  1995-04       Impact factor: 4.638

4.  Bovine gamma/delta T-cell proliferation is associated with self-derived molecules constitutively expressed in vivo on mononuclear phagocytes.

Authors:  A J Okragly; M Hanby-Flarida; D Mann; C L Baldwin
Journal:  Immunology       Date:  1996-01       Impact factor: 7.397

5.  Vascular cell adhesion molecule 1 and alpha 4 and beta 1 integrins in lymphocyte aggregates in Sjögren's syndrome and rheumatoid arthritis.

Authors:  J C Edwards; L S Wilkinson; P Speight; D A Isenberg
Journal:  Ann Rheum Dis       Date:  1993-11       Impact factor: 19.103

6.  Elevated numbers of gamma-delta (gamma delta+) T lymphocytes in children with immune thrombocytopenic purpura.

Authors:  R E Ware; T A Howard
Journal:  J Clin Immunol       Date:  1994-07       Impact factor: 8.317

7.  Increase of circulating gamma/delta T lymphocytes in the peripheral blood of patients affected by active inflammatory bowel disease.

Authors:  R Giacomelli; I Parzanese; G Frieri; A Passacantando; F Pizzuto; T Pimpo; P Cipriani; A Viscido; R Caprilli; G Tonietti
Journal:  Clin Exp Immunol       Date:  1994-10       Impact factor: 4.330

8.  Natural killer cells and gamma delta T cells in scleroderma: relationship to disease duration and anti-Scl-70 antibodies.

Authors:  R F Holcombe; B A Baethge; R E Wolf; K W Betzing; R M Stewart
Journal:  Ann Rheum Dis       Date:  1995-01       Impact factor: 19.103

9.  An immunohistochemical study of immunological phenomena in minor salivary glands in patients with Sjögren's syndrome.

Authors:  A Caretto; P A Ostuni; F Chieco-Bianchi; B Pedini; A C Spadaccino; M Bagnasco; S Todesco; C Betterle
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

10.  Lymphocyctes Tgammadelta in clinically normal skin and peripheral blood of patients with systemic lupus erythematosus and their correlation with disease activity.

Authors:  E Robak; H Niewiadomska; T Robak; J Bartkowiak; J Z Błoński; A Woźniacka; L Pomorski; A Sysa-Jedrezejowska
Journal:  Mediators Inflamm       Date:  2001-08       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.